Home › Obstructive Sleep Apnea › NCT06189755
MicroRNAs as Biomarkers for Obstructive Sleep Apnea
RecruitingObservational study
Who can join
Ages 18 to 75 · All sexes
Full eligibility criteria
Inclusion Criteria for Cases: * age 18-75 years * moderate-severe OSA (defined as AHI ≥15 events/hour) * willing to accept PAP therapy Inclusion Criteria for Controls: * age 18-75 years * no OSA (defined as AHI \<5 events/hour) Exclusion Criteria for Cases: * current use of PAP or other OSA treatments * home oxygen therapy * recent changes (within 3 months) to BP medications among those who are on these medications * presence of Cheyne-Stokes Respiration (CSR) in sleep study * predominantly central sleep apnea (AHI≥15 events/hour, with \>50% central events) * pregnancy * clinical history of chronic kidney disease (Stage 5) requiring dialysis, or renal transplant * organ transplantation * self-reported sleep duration less than 5 hours per night on weeknights (work nights) * current night shift work Exclusion Criteria for Controls: * home oxygen therapy * pregnancy * clinical history of chronic kidney disease (Stage 5) requiring dialysis, or renal transplant * organ transplantation * self-reported sleep duration less than 5 hours per night on weeknights (work nights) * current night shift work
About the study
Although obstructive sleep apnea (OSA) is a common disorder, there are no blood biomarkers for identification and management of these patients. This project will study microRNAs in order to develop and validate blood biomarkers that are specific to OSA, useful for identification of cases with OSA, reflective of efficacy of therapy, and able to predict blood pressure response to treatment of OSA.
What is being tested
- Positive Airway Pressure (device)
Sponsor: University of Pennsylvania · Participants: 500 · Started: Apr 1, 2024
Contact the study team
- Colleen M Walsh, MS · Phone: 215-614-0047
- Kristie C Nguyen · Phone: 215-615-4112
Official record on ClinicalTrials.gov — NCT06189755
Locations in the U.S.
| Ohio | The Ohio State University - Martha Morehouse Medical Pavilion, Suite 2600, Columbus |
| Pennsylvania | University of Pennsylvania, Philadelphia |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.